Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.06% Nasdaq Down0.01%

Transcept Pharmaceuticals, Inc. (TSPT)

-NGM

3.10 Up 0.02(0.65%) 4:00PM EDT

Add to Portfolio
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 30, 2013Dec 30, 2012Sep 29, 2012Jun 29, 2012
Net Income (10,500) (6,554) 4,855   (5,140)
Operating Activities, Cash Flows Provided By or Used In
Depreciation182  137  151  100  
Adjustments To Net Income811  730  740  686  
Changes In Accounts Receivables -   -   -   -  
Changes In Liabilities(550)(701)266  591  
Changes In Inventories -   -   -   -  
Changes In Other Operating Activities5,787  (7,138)489  (870)
Total Cash Flow From Operating Activities (4,270) (13,526) 6,501   (4,633)
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures(2)(9)(22)(10)
Investments(5,602)(17,366)14,500  13,499  
Other Cash flows from Investing Activities -   -   -   -  
Total Cash Flows From Investing Activities (5,604) (17,375) 14,478   13,489  
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid -   -   -   -  
Sale Purchase of Stock214  232  64  37,819  
Net Borrowings -   -   -   -  
Other Cash Flows from Financing Activities -   -   -   -  
Total Cash Flows From Financing Activities 214   232   64   37,819  
Effect Of Exchange Rate Changes -   -   -   -  
Change In Cash and Cash Equivalents (9,660) (30,669) 21,043   46,675  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.